Risk Factors for Febrile Neutropenia in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Undergoing Initial R-CHOP Treatment.

Background: Febrile neutropenia (FN) frequently occurs as a complication among patients with diffuse large B-cell lymphoma (DLBCL) receiving their initial rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. This study aimed to identify the risk factors for FN...

Full description

Bibliographic Details

Published in:	Clinical Medicine Insights: Oncology Vol. 20; pp. 1 - 9
Main Authors:	Chen, Liang-Ying, Tsai, Che-An, Liao, Po-Wei, Teng, Ling-Chiao, Lin, Cheng-Hsien, Su, Yu-Chen, Teng, Chieh-Lin Jerry
Format:	research tables/charts Journal Article
Published:	Sage Publications Inc. 2/18/2026
Online Access:	View this record in EBSCOhost